Retzius‐sparing RALP vs standard RALP
Serious adverse events · men (ages > 18 years) with clinically localized prostate cancer
It is very uncertain whether retzius‐sparing RALP changes serious adverse events compared with standard RALP (very low certainty).
1 finding from 1 review
- Retzius‐sparing versus standard robotic‐assisted laparoscopic prostatectomy for the treatment of clinically localized… 2020 · Cochrane Headline outcomes onlyRR 1.4 [0.47, 4.17]2 studies · 230 participantsVery low